LINC02389/miR-7-5p Regulated Cisplatin Resistance of Non-Small-Cell Lung Cancer via Promoting Oxidative Stress
Background. Non-small-cell lung cancer (NSCLC) is one of the most common malignancies worldwide, and cisplatin-based chemotherapy is the main treatment for NSCLC. However, cisplatin resistance of NSCLC cells is a major challenge for NSCLC treatment. Materials and Methods. qRT-PCR and Western blot we...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Analytical Cellular Pathology |
Online Access: | http://dx.doi.org/10.1155/2022/6100176 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!